Microscopic images of the various types of fat tissues developed in mice after transplantation. Top panels show the fat tissue’s general morphology, and the bottom panels are the tissue sections stained with hUCP1 (red color), which is unique for brown fat cells. These images show that while the HUMBLE fat cells are morphologically similar to the white fat cells, they express the brown fat specific hUCP1 protein. (Joslin Diabetes Center)
Studies in mice offer a proof of concept that ‘HUMBLE’ cells, created from human white fat, can treat metabolic diseases.
Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus. Scientists at Joslin Diabetes Center have delivered a proof of concept for a novel cell-based therapy against this dangerous condition.
The potential therapy for obesity would transplant HUMBLE (human brown-like) fat cells, human white fat cells that have been genetically modified to become similar to heat-generating brown fat cells, says Yu-Hua Tseng, PhD, a Senior Investigator in Joslin’s Section on Integrative Physiology and Metabolism.
Brown fat cells burn energy instead of storing energy as white fat cells do, says Tseng, senior author on a paper about the work in Science Translational Medicine . In the process, brown fat can lower excessive levels of glucose and lipids in the blood that are linked to metabolic diseases such as diabetes.
However, people who are overweight or obese tend to have less of this beneficial brown fat—a barrier that HUMBLE cells are designed to overcome, Tseng says.
She and her colleagues created the cells from human white fat cells in a progenitor stage (not yet fully developed into their final fat form). The investigators used a variant of the CRISPR-Cas9 genome editing system to boost expression of a gene called UCP1, which triggers white fat cell progenitors to develop into brown fat-like cells.
Transplanted into mice lacking an immune system, the HUMBLE progenitor cells developed into cells that functioned very much like the mice’s own brown fat cells, says Tseng, who is also a professor of medicine at Harvard Medical School.
Her team compared transplants of these cells versus the original white fat cells in mice who were put on a high fat diet. Mice given the HUMBLE transplants displayed much greater sensitivity to insulin and ability to clear glucose from the blood (two key factors that are impaired in type 2 diabetes).
Additionally, the mice receiving HUMBLE transplants put on less weight than mice with transplanted white fat cells, remaining in the same range as animals who received brown fat cells.
Perhaps surprisingly, the Joslin scientists demonstrated that these benefits were mostly due to signals from the transplanted cells to endogenous (existing) brown fat cells in the mice. “Cells in different tissues communicate with each other,” Tseng says. “In this case, we found that our transplanted HUMBLE cells secrete a molecule called nitric oxide, which is carried by red blood cells to the endogenous brown cells and activates those cells.”
If the HUMBLE technique continues to prove out in pre-clinical research, it might eventually be possible to generate this type of cell for individual patients, Tseng suggests. Such a procedure would remove a tiny amount of a patient’s white fat cells, isolate the progenitor cells, modify those cells to boost expression of UCP1, and then return the resulting HUMBLE cells to the patient.
However, that individualized approach would be complicated and expensive, so the Tseng lab is pursuing two alternative routes that may be more practical for clinical use.
One alternative is to use cells that are not personalized but instead are encapsulated via biomaterials that protect the cells from rejection by a patient’s immune system. (Joslin researchers and their collaborators have long studied such materials for cell transplants for type 1 diabetes.) The other option is gene therapies that directly express the UCP1 gene in white fat progenitor cells in the body, so that those cells acquire HUMBLE-like properties.
Tseng emphasizes that this research is moving ahead despite the Covid-19 pandemic, which puts people with diabetes at much higher risk of serious outcomes if they are infected.
“Employing cell-based or gene therapies to treat obesity or type 2 diabetes used to be science fiction,” she says. “Now scientific advances, such as CRISPR gene-editing technologies, will help us to improve the metabolism, the body weight, the quality of life and the overall health of people with obesity and diabetes.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- More belly weight increases danger of heart disease even if BMI does not indicate obesityon April 22, 2021 at 4:02 am
People with abdominal obesity and excess fat around the body's mid-section and organs have an increased risk of heart disease even if their body mass index (BMI) measurement is within a healthy weight ...
- Circadian clock dysfunction in human omental fat links obesity to metabolic inflammationon April 22, 2021 at 3:53 am
Whether chronic inflammation contributes to metabolic disease through the dysregulation of circadian systems remains incompletely understood in humans. Here the authors show that circadian clock ...
- Obesity, metabolic health, and urological disorders in adults: a nationwide population-based studyon April 22, 2021 at 2:51 am
We evaluate the risks of various urological disorders that require treatments according to obesity and metabolic health status using a nationwide dataset of the Korean population. 3,969,788 patients ...
- Novo Nordisk plans study of oral semaglutide in obesityon April 22, 2021 at 1:39 am
Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, the Danish pharma company announced yesterday. The decision to begin this study follows the completion of ...
- WCM-Q research probes mechanisms of premature aging of fat cells in obesityon April 21, 2021 at 10:31 pm
Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have gained new insight into the molecular mechanisms by which obesity leads to premature aging of fat cells, and then to chronic inflammation, ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Cells to Civilizations: The Principles of Change That Shape Lifeon April 21, 2021 at 9:06 pm
Cells to Civilizationsis the first unified account of how life transforms itself--from the production of bacteria to the emergence of complex civilizations.
- Safe Sex for Folks Over 65on April 20, 2021 at 3:07 pm
More than 1,000 people ages 65 to 80 were polled, and nearly three-quarters said they had a romantic partner, and 54 percent of them were sexually active. They claim that they’re not shy about it, ...
- General Motors announces electric vehicle battery factory in Spring Hillon April 17, 2021 at 7:32 am
General Motors will build a second U.S. electric vehicle battery factory in Spring Hill, the company announced at a press conference Friday.
- Food trucks are coming to Baton Rouge Metro Airporton April 16, 2021 at 9:11 am
Could it be true? Food trucks at the Baton Rouge Metro Airport? Yes, it is true, food trucks will be available in the BTR Airport Cell Phone Lot on Saturday, ...
- 'I had cancer, but cancer didn't have me.' How a new procedure helped a Porter woman become cancer-freeon April 14, 2021 at 6:57 pm
The Porter resident and her sister Dawn Adams, from St. Louis, were crisscrossing the country, stopping at National Parks along the way. The two drove through Missouri and South Dakota, went to Mt.